SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-072154
Filing Date
2024-08-23
Accepted
2024-08-23 15:11:44
Documents
2
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2779
2 POWER OF ATTORNEY ea021229701ex24-1_estrella.htm EX-24.1 4731
  Complete submission text file 0001213900-24-072154.txt   9039
Mailing Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Issuer) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ESTRELLA IMMUNOPHARMA, INC. 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608
Business Address
Zhang Hong (Reporting) CIK: 0002033474 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40608 | Film No.: 241235968